(TNON) Tenon Medical - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US88066N1054
TNON: Surgical Implant Systems, Joint Fusion Devices
Tenon Medical, Inc. (NASDAQ:TNON) is a medical device company specializing in the development of surgical implant systems designed to address severe lower back pain. The companys primary focus is on treating sacroiliac joint dysfunction, a common cause of lower back pain, through its innovative CATAMARAN SI-Joint Fusion System. This system is engineered to fuse the sacroiliac joints (SI-Joints), providing stability and relief from pain. The device features a unique fixation mechanism that traverses the axial and sagittal planes of the ilium and sacrum, ensuring robust transfixation of the SI joints for optimal outcomes.
Founded in 2012 and headquartered in Los Gatos, California, Tenon Medical operates in the United States and Puerto Rico. The companys flagship product, the CATAMARAN SI-Joint Fusion System, is distinguished by its minimally invasive approach, which aims to reduce recovery time and improve patient outcomes. The systems design reflects Tenon Medicals commitment to addressing the complexities of SI-Joint dysfunction, a condition often underdiagnosed but prevalent among patients with chronic lower back pain.
Tenon Medical, Inc. is listed on the NASDAQ exchange under the ticker symbol TNON. The company falls under the Health Care Equipment category within the GICS Sub Industry classification. For more information, investors and patients can visit the companys website at https://www.tenonmed.com.
3-Month Forecast:
Based on the provided
Technical Outlook: - The stock is currently trading at $1.51, below its 20-day SMA of $1.38 but above its 50-day SMA of $1.61. This indicates potential short-term weakness but medium-term resistance. - The 200-day SMA of $3.53 suggests significant downside from its longer-term average, indicating a bearish trend. - Average trading volume of 55,050 shares over the last 20 days and an ATR of 0.13 suggest low volatility and limited near-term price movement.
Fundamental Outlook: - The companys market cap of $4.08M reflects its micro-cap status, indicating higher risk and potential volatility. - A P/B ratio of 0.96 suggests the stock is trading near book value, which could indicate undervaluation or financial distress. - The P/S ratio of 1.23 indicates modest revenue multiples, though the lack of profitability (P/E: 0.00) raises concerns about the companys ability to generate earnings.
3-Month Forecast: - Technical Data: Expect sideways to slightly bearish movement in the near term, with resistance at $1.61 (50-day SMA) and support at $1.38 (20-day SMA). - Fundamental Data: The companys low market cap and lack of profitability may limit upside potential, though its focus on a specific medical niche could attract specialized investors.
Additional Sources for TNON Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TNON Stock Overview
| Market Cap in USD | 7m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception | 2022-04-27 |
TNON Stock Ratings
| Growth Rating | -73.8 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | -82.1 |
| Analysts | 4.5/5 |
| Fair Price Momentum | 1.07 USD |
| Fair Price DCF | - |
TNON Dividends
No Dividends PaidTNON Growth Ratios
| Growth Correlation 3m | -52% |
| Growth Correlation 12m | -94.7% |
| Growth Correlation 5y | -97.4% |
| CAGR 5y | -91.19% |
| CAGR/Max DD 5y | -0.91 |
| Sharpe Ratio 12m | -1.00 |
| Alpha | -100.19 |
| Beta | 2.257 |
| Volatility | 111.93% |
| Current Volume | 222.8k |
| Average Volume 20d | 305.9k |
As of May 10, 2025, the stock is trading at USD 1.13 with a total of 222,827 shares traded.
Over the past week, the price has changed by -3.42%, over one month by -1.74%, over three months by -22.34% and over the past year by -83.18%.
No, based on ValueRay Analyses, Tenon Medical (NASDAQ:TNON) is currently (May 2025) a stock to sell. It has a ValueRay Growth Rating of -73.75 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TNON as of May 2025 is 1.07. This means that TNON is currently overvalued and has a potential downside of -5.31%.
Tenon Medical has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy TNON.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TNON Tenon Medical will be worth about 1.3 in May 2026. The stock is currently trading at 1.13. This means that the stock has a potential upside of +13.27%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 3 | 165.5% |
| Analysts Target Price | 3 | 165.5% |
| ValueRay Target Price | 1.3 | 13.3% |